Atlas Trials

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 in Healthy Participants

Clinical trial NCT06326606 · COMPLETED

Trial details

NCT number
NCT06326606
Sponsor
MycoMedica Life Sciences PBC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2024-03-27
Primary completion
2024-07-08
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.